πŸ‡ΊπŸ‡Έ FDA
Patent

US 9089599

Low affinity FCGR deficient mice

granted A61KA61K49/0008

Quick answer

US patent 9089599 (Low affinity FCGR deficient mice) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K49/0008